A 66-year-old man heavy smoker complains of exertional dyspnea that has progressed over the last two years. He has a new diagnosis of chronic obstructive pulmonary disease. Which of the following agents is most likely to reduce this patient's symptoms?
سؤال مجاني 4 من 10 اليوم · اشترك وكمّل بدون حد
اعرض الإجابة
الإجابة والشرح
ادخل لحسابك عشان نحفظ إجاباتك ونوريك أخطاءك.
الإجابة: C. Muscarinic antagonist
COPD symptoms are treated with bronchodilators: antimuscarinics (ipratropium, tiotropium) and/or beta-2 agonists. A muscarinic antagonist is the only bronchodilator offered. Beta-blockers, alpha-blockers and alpha-2 agonists do not relieve dyspnoea in COPD.
ليش كل خيار صح أو غلط
-
B
ليش غلط
Beta blockers are listed among the drugs that trigger COPD exacerbations; they do not relieve dyspnea.
✓ COPD.pdf · p. 10 -
C
ليش صح
COPD is treated with bronchodilators (antimuscarinics, beta-2 agonists, or both); a muscarinic antagonist such as ipratropium or tiotropium relieves symptoms.
✓ Step Up To Medicine 6th Edition 2024 (COPD).pdf · p. 9
- المصدر
- Step Up To Medicine 6th Edition 2024 (COPD).pdf · p. 9
Step Up To Medicine 6th Edition 2024 (COPD).pdf · p. 7 - المحاضرة
- COPD · Pulmonology · Module B
- ظهر في
- Respi bank · MED41 ♂ EOM B